These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effect of heparin and low molecular weight heparins on thrombin-induced blood platelet activation in the absence of antithrombin III. Baruch D, Franssen J, Hemker HC, Lindhout T. Thromb Res; 1985 Jun 01; 38(5):447-58. PubMed ID: 3160132 [Abstract] [Full Text] [Related]
32. Reaction of thrombins with human antithrombin III: II. Dependence of rate of inhibition on molecular form and origin of thrombin. Latallo ZS, Jackson CM. Thromb Res; 1986 Sep 01; 43(5):523-37. PubMed ID: 3755846 [Abstract] [Full Text] [Related]
33. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin]. Kudriashov BA, Pastorova VE, Liapina LA. Biokhimiia; 1981 Nov 01; 46(11):2024-9. PubMed ID: 7317530 [Abstract] [Full Text] [Related]
38. Requirement of lysine residues outside of the proposed pentasaccharide binding region for high affinity heparin binding and activation of human antithrombin III. Kridel SJ, Chan WW, Knauer DJ. J Biol Chem; 1996 Aug 23; 271(34):20935-41. PubMed ID: 8702852 [Abstract] [Full Text] [Related]
39. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin. Olson ST, Swanson R, Raub-Segall E, Bedsted T, Sadri M, Petitou M, Hérault JP, Herbert JM, Björk I. Thromb Haemost; 2004 Nov 23; 92(5):929-39. PubMed ID: 15543318 [Abstract] [Full Text] [Related]